CORONA Remedies sets record by screening over 21,000 patients for neuropathy

New Delhi: CORONA Remedies has achieved a new milestone by setting an Asia record for screening the highest number of patients for peripheral neuropathy using a biothesiometer in a single week. This achievement, recognized by the Asia Book of Records, took place during Neuropathy Awareness Week from May 5 to 11, 2024.

The initiative saw a dedicated team from CORONA Remedies screening 21,012 patients with the assistance of 1,231 doctors at neuropathy detection camps across India. This effort was part of the company’s broader “Mission Heal India” initiative, which aims to enhance health awareness and provide early diagnosis to prevent long-term suffering. The screenings were conducted in collaboration with local healthcare providers, clinics, hospitals, and community leaders in urban centers, rural villages, and remote areas.

Nirav K. Mehta, Promoter & Executive Director of CORONA Remedies, highlighted, “This record is about raising awareness and providing early diagnoses to thousands who might otherwise suffer in silence. Peripheral neuropathy can significantly impact quality of life. We are dedicated to screening peripheral neuropathy regularly throughout the year, aiming to make more patients about the condition. We aim to make a lasting difference in patients’ lives through ‘Mission Heal India’ with the support of the wider medical fraternity.”

Peripheral neuropathy, which affects millions globally, is particularly prevalent among individuals with diabetes, endocrine disorders, or vitamin B12 deficiencies. Contributing factors include dietary patterns, especially vegetarian or vegan diets that can lead to vitamin B12 and vitamin D deficiencies, heavy alcohol intake, exposure to toxins, side effects of certain medications, and genetic disorders. Early detection is crucial for effective management, particularly among diabetic patients, as 50% of such patients remain asymptomatic to neuropathy. Without timely intervention, the condition can lead to serious complications like foot ulcers, potentially resulting in amputations.

This initiative not only raised awareness but also provided valuable epidemiological insights. Notably, the prevalence of severe neuropathy is 2.67 times higher and moderate neuropathy is 2.56 times higher among diabetic patients compared to others.